Targeting KIT on innate immune cells enhances the antitumor activity of checkpoint inhibitors in vivo
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-O12
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gedrich, Richard
Seibel, Scott
LaVallee, Theresa
Eder, Joseph Paul
Article History
First Online: 4 November 2015